Corundum Trust Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Buy
+1,824
New +$211K 0.5% 44
2025
Q4
Sell
-1,963
Closed -$165K 94
2025
Q3
$165K Buy
+1,963
New +$162K 0.36% 45
2024
Q4
Sell
-1,982
Closed -$225K 51
2024
Q3
$225K Hold
1,982
0.62% 31
2024
Q2
$245K Buy
+1,982
New +$255K 0.71% 32
2023
Q3
$292K Sell
2,835
-15
-0.5% -$1.62K 0.87% 26
2023
Q2
$329K Buy
+2,850
New +$324K 0.9% 24

Other funds holding MRK

Corundum Trust Company's MRK Position: Q1 2026 in Review

Corundum Trust Company opened a new position in Merck (MRK) in Q1 2026: 1,824 shares worth $219K. The stake represents 0.5% of the portfolio and ranks #44 among its holdings. This is a return to the name: Corundum Trust Company previously reported a position in MRK as recently as Q3 2025.

Corundum Trust Company first reported a position in MRK in Q2 2023 and has held it in 6 quarters since. The position peaked at $329K in Q2 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Corundum Trust Company held 1,824 shares of Merck worth $219K as of Q1 2026.
  • Merck was a new Corundum Trust Company position in Q1 2026.
  • Merck made up 0.5% of Corundum Trust Company's portfolio in Q1 2026, its #44 holding.
  • Corundum Trust Company first reported a position in Merck in Q2 2023 and has held it in 6 quarters since.
  • Corundum Trust Company's Merck position peaked at $329K in Q2 2023.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Corundum Trust Company's 13F filing for Q1 2026, filed 15 Apr 2026.